Position in OCUL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,965,797
-$3,535,649 QoQ
Shares Held
1,218,513
-33.4% QoQ
Ownership
0.555%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#30
of 257 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCUL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,272,047,596 across 342 Biotechnology names. OCUL ranks #78 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in OCUL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,965,797 | 1,218,513 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $15,501,446 | 1,830,159 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,621,855 | 380,713 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,737,949 | 234,213 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,028,520 | 110,832 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,380,815 | 461,230 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,160,099 | 252,939 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,804,562 | 207,421 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,667,053 | 536,119 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $176,658 | 19,413 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $495,060 | 111,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $364,554 | 116,100 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $703,308 | 136,300 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,704,444 | 323,424 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $531,328 | 189,085 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $820,704 | 197,760 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $2,392,255 | 483,284 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,274,966 | 469,866 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,954,000 | 895,400 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $14,691,118 | 1,036,045 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $19,174,395 | 1,168,458 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $19,050,106 | 920,295 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,513,583 | 330,300 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,573,661 | 188,915 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $120,586 | 24,361 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||